secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K/A
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001493152-23-038380
Event type: m_and_a
Sentiment:  negative
Materiality: 0.60
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant acquires Surgalign assets; Surgalign reports Q1 2023 revenue $16.7M, net income $4.1M with going concern doubt
--------------------------------------------------------------------------------

- Surgalign Q1 2023 revenue $16.7M (down 19% YoY); net income $4.1M included $12.6M gain on Coflex sale.
- Surgalign had $22.4M cash, $620M accumulated deficit; management expressed substantial doubt about going concern.
- Surgalign not in compliance with Nasdaq listing requirements as of April 2023.
- Xtant acquired Coflex/Cofix product lines for $17M cash; this 8-K/A provides Surgalign historical financials.
- Pro forma condensed combined financial statements filed, giving effect to the acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223038380/0001493152-23-038380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223038380/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-038380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer